Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	616.21	944.07	1,316	1,550	380.8	495.29
Cash & Short-Term Investments	616.21	944.07	1,316	1,550	380.8	495.29
Cash Growth	-41.27%	-28.25%	-15.11%	307.04%	-23.12%	-
Accounts Receivable	23.94	17.9	82.47	136.14	21.91	7.68
Other Receivables	-	1.55	1.56	-	-	-
Receivables	24.47	31.74	84.03	147.7	24.17	8.78
Inventory	-	0.05	4.36	3.51	9.27	-
Prepaid Expenses	18.95	20.42	35.11	18.94	10.85	2.55
Restricted Cash	2.86	4.79	8.22	-	-	-
Other Current Assets	-	0.68	2.57	2.9	1.44	5.3
Total Current Assets	662.48	1,002	1,450	1,723	426.54	511.93
Property, Plant & Equipment	616.95	397.22	718.79	145.77	121.44	63.13
Long-Term Investments	62.1	78.57	113.73	115.23	103.12	107.25
Goodwill	-	49.24	60.21	21.31	1.86	1.86
Other Intangible Assets	79.57	82.74	111.04	21.64	3.29	3.84
Other Long-Term Assets	45.18	42.22	47.81	43.99	5.6	5.58
Total Assets	1,481	1,665	2,539	2,071	675.15	697.32
Accounts Payable	15.7	9.32	10.45	8.19	13.89	2.44
Accrued Expenses	65.54	50.73	52.3	85.14	17.73	13.6
Current Portion of Leases	-	19.93	29.33	0.75	0.49	0.6
Current Unearned Revenue	22.89	48.5	47.82	33.24	28.82	21.82
Other Current Liabilities	10.3	35.38	33.06	7.45	12.29	1.62
Total Current Liabilities	114.43	163.86	172.96	134.76	73.22	40.07
Long-Term Leases	445.59	222.32	413.26	22.28	16.52	16.77
Long-Term Unearned Revenue	105.25	158.06	174.77	155.99	99.65	126.08
Other Long-Term Liabilities	17.67	23.95	42.06	190.58	15.71	12.55
Total Liabilities	682.94	568.19	803.04	503.61	205.1	195.47
Common Stock	0.01	0.2	0.19	0.16	0.13	0.08
Additional Paid-In Capital	6,528	6,386	6,136	3,805	929.13	834.08
Retained Earnings	-5,730	-5,291	-4,398	-2,298	-467.88	-341.27
Comprehensive Income & Other	0.26	1.48	-2.63	-1.72	-	-
Total Common Equity	797.94	1,097	1,736	1,505	461.38	492.89
Minority Interest	-	-	-	62.01	8.68	8.79
Shareholders' Equity	797.94	1,097	1,736	1,567	470.05	501.85
Total Liabilities & Equity	1,481	1,665	2,539	2,071	675.15	697.32
Total Debt	445.59	242.25	442.59	23.03	17	17.37
Net Cash (Debt)	170.62	701.82	873.2	1,527	363.8	477.92
Net Cash Growth	-73.57%	-19.63%	-42.81%	319.73%	-23.88%	-
Net Cash Per Share	3.36	14.44	20.79	44.90	11.42	16.64
Filing Date Shares Outstanding	53.08	50.03	51.81	43.99	7.85	28.73
Total Common Shares Outstanding	53.08	50.03	47.3	40.28	7.85	28.73
Working Capital	548.05	837.89	1,277	1,588	353.32	471.85
Book Value Per Share	15.03	21.93	36.71	37.37	58.77	2526.92
Tangible Book Value	718.38	965.17	1,565	1,462	456.23	487.19
Tangible Book Value Per Share	13.53	19.29	33.09	36.30	58.11	2497.70
Land	6.06	6.06	6.06	-	-	-
Machinery	171.76	168.42	206.72	128.75	56.14	38.27
Construction In Progress	57.98	15.83	23.43	10.28	42.58	0.89
Leasehold Improvements	77.85	71.56	125.31	55.03	40.44	29.37

Source: S&P Capital IQ. Standard template. Financial Sources.